Pfizer's Trumenba just got closer to a new FDA nod. Can it catch up to...

Discussion in 'Pharma/Biotech Companies - In the News' started by cafead, Apr 25, 2018 at 11:12 AM.

  1. #1 cafead, Apr 25, 2018 at 11:12 AM
    cafead

    cafead Administrator
    Staff Member

    Joined:
    Nov 21, 2001
    Messages:
    33,028
    Likes Received:
    3
    via Hot on the heels of men B rival GlaxoSmithKline, Pfizer's vaccine Trumenba picked up an FDA “breakthrough” designation that could speed its move toward a bigger market. And with the Pfizer shot's sales lagging behind GSK's Bexsero, Trumenba could use the lift.

    article source
     
    Quote

Reply to Thread